-transparent.png){kind=logo}
The capacity of complement-mediated solubilization of immune complexes (complex releasing activity: CRA) was studied in 63 sera from eight systemic lupus erythematosus (SLE) patients. CRA in sera of active SLE (35 +/- 17.%) was significantly lower than that of inactive SLE (64.1 +/- 24.1%, P less than 0.001). In addition, 20 of 23 sera collected during active diseases demonstrated CRA values less than 50% of the control pooled serum. On the other hand, CRA of 29 of 40 sera from inactive disease exceeded the 50% level. CRA in SLE sera correlated with complement component levels and in particular with the CH50. Serial determination of CRA and of levels of circulating immune complexes (CIC), C4 and C3 in two active patients indicated that the correlation between CRA and the complement components was positive, while that between CRA and CIC was negative. These studies provide evidence that CRA may be useful for following the activity of SLE and that CRA reflects the levels of the complement components of both classical and alternative pathways. The possibility that CIC may be solubilized and opsonized by complement and cleared by the reticuloendothelial system was discussed.
T Sakurai, and
T Fujita, and
I Kono, and
T Kabashima, and
K Yamane, and
N Tamura, and
H Kashiwagi
July 1985,
The International journal of artificial organs,
T Sakurai, and
T Fujita, and
I Kono, and
T Kabashima, and
K Yamane, and
N Tamura, and
H Kashiwagi
January 1981,
Arthritis and rheumatism,
T Sakurai, and
T Fujita, and
I Kono, and
T Kabashima, and
K Yamane, and
N Tamura, and
H Kashiwagi
December 1981,
Clinical and experimental immunology,
T Sakurai, and
T Fujita, and
I Kono, and
T Kabashima, and
K Yamane, and
N Tamura, and
H Kashiwagi
August 1989,
Nihon Jinzo Gakkai shi,
T Sakurai, and
T Fujita, and
I Kono, and
T Kabashima, and
K Yamane, and
N Tamura, and
H Kashiwagi
January 1970,
Folia allergologica,
T Sakurai, and
T Fujita, and
I Kono, and
T Kabashima, and
K Yamane, and
N Tamura, and
H Kashiwagi
May 1981,
Medicine,
T Sakurai, and
T Fujita, and
I Kono, and
T Kabashima, and
K Yamane, and
N Tamura, and
H Kashiwagi
January 1996,
British journal of rheumatology,
T Sakurai, and
T Fujita, and
I Kono, and
T Kabashima, and
K Yamane, and
N Tamura, and
H Kashiwagi
January 1982,
Medicina clinica,
T Sakurai, and
T Fujita, and
I Kono, and
T Kabashima, and
K Yamane, and
N Tamura, and
H Kashiwagi
August 1977,
Clinical and experimental immunology,
T Sakurai, and
T Fujita, and
I Kono, and
T Kabashima, and
K Yamane, and
N Tamura, and
H Kashiwagi
February 1988,
The Journal of rheumatology,
